C.H. Robinson received the Community Impact Award in the Workplace Giving Campaign category from Minnesota Business magazine. The honor recognizes a successful volunteer or employee-giving campaign benefiting any non-profit or other worthy organization.
This is the second year in a row that Minnesota Business has recognized C.H. Robinson in the Workplace Giving Campaign category in recognition of various employee volunteer campaigns that the company facilitates. This year, C.H. Robinson was presented the award for the company’s 14 years of support and dedication to the MinnDakotas chapter of JDRF, the leading global organization focused on type 1 diabetes (T1D) research.
“We are so appreciative of the many years of support that C.H. Robinson has given our chapter of JDRF,” says Ross Marcus, development manager at JDRF MinnDakotas. “They continue to participate as one of our largest corporate teams during our annual Walk to Cure Diabetes at the Mall of America.”
Each year, C.H. Robinson’s employees gather at the Mall of America in Bloomington, Minn., to participate in the annual Walk to Cure Diabetes. The passion of C.H. Robinson’s employees has been the engine of growth behind this event. What began as a small group of employees who participated in the Walk in 2001, has now grown to 645 Team Robinson walkers who participated in this year’s walk.
“We are proud of the work our employees do to make C.H. Robinson a great company,” says Angie Freeman, vice president of human resources at C.H. Robinson. “Awards like this are a reminder that giving back is embedded in our company culture and that the same ingenuity and hard work that help us succeed as a company, also help make our communities better places to live and work.”
The Mall of America is JDRF’s single largest fundraising site in the U.S., raising the most money and attracting the most participants. Since 2001, C.H. Robinson and its employees have raised over $548,000 for the MinnDakota’s chapter of JDRF. The funds go toward improving the lives of people affected by diabetes by funding the research to treat, cure, and prevent T1D.